Invesco’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
60,395
+5,792
+11% +$20.8K ﹤0.01% 3467
2025
Q4
$187K Buy
54,603
+11,914
+28% +$53.2K ﹤0.01% 3546
2025
Q3
$215K Buy
42,689
+5,577
+15% +$24.6K ﹤0.01% 3545
2025
Q2
$127K Buy
37,112
+12,966
+54% +$32.3K ﹤0.01% 3616
2025
Q1
$53.8K Buy
24,146
+12,893
+115% +$37K ﹤0.01% 3690
2024
Q4
$33K Buy
11,253
+303
+3% +$844 ﹤0.01% 3722
2024
Q3
$28.5K Sell
10,950
-2,793
-20% -$7.74K ﹤0.01% 3731
2024
Q2
$40.7K Buy
13,743
+2,315
+20% +$8.76K ﹤0.01% 3836
2024
Q1
$51.8K Buy
+11,428
New +$58.3K ﹤0.01% 3798
2023
Q2
Sell
-95,208
Closed -$718K 3859
2023
Q1
$718K Buy
95,208
+17,017
+22% +$155K ﹤0.01% 3075
2022
Q4
$792K Sell
78,191
-3,863
-5% -$44.6K ﹤0.01% 3035
2022
Q3
$812K Buy
82,054
+4,695
+6% +$51.5K ﹤0.01% 3004
2022
Q2
$824K Buy
+77,359
New +$655K ﹤0.01% 3077
2021
Q4
Sell
-28,110
Closed -$563K 4025
2021
Q3
$563K Buy
28,110
+13,854
+97% +$245K ﹤0.01% 3375
2021
Q2
$314K Buy
+14,256
New +$393K ﹤0.01% 3610

Other funds holding ABCL